SCHEMBL6606041

SCHEMBL6606041

Cc1cc(N(C)C)c2ccc(N)cc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 4/20 0.50
LMNA P02545 3/20 0.44
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CASP6 P55212 1/20 0.44
NR4A2 P43354 1/20 0.44
TERT O14746 4/20 0.43
MDM4 O15151 1/20 0.42
NCF1 P14598 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
F2 P00734 1/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
MAOA P21397 1/20 0.38
DRD1 P21728 1/20 0.38
ACHE P22303 1/20 0.38
PTGS1 P23219 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073181 0.88 TERT (0.55) NQO2LMNAPOLBKDM4ECASP6
SCHEMBL6614139 0.79 TERT (0.43) NQO2LMNAPOLBKDM4ENR4A2
SCHEMBL6600579 0.79 POLB (0.64) POLBNR4A2TERTKMT2A
SCHEMBL6639402 0.78 POLB (0.61) NQO2LMNAPOLBKDM4ECASP6
SCHEMBL6790532 0.77 CYP1A2 (0.60) KDM4ETERTNCF1ADORA2A
SCHEMBL6607835 0.76 TERT (0.46) POLBKDM4ENR4A2TERTNCF1
SCHEMBL11690458 0.75 NQO2 (0.53) NQO2LMNAPOLBKDM4ECASP6
SCHEMBL10818642 0.74 MDM4 (0.43) NQO2LMNAPOLBKDM4ECASP6
SCHEMBL13701566 0.71 LMNA (0.58) LMNAKDM4ETERTKMT2AMAOA
SCHEMBL10005317 0.71 NQO2 (0.49) NQO2LMNAPOLBKDM4ECASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373252-A1 CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT Aventis Pharma S.A. (FR) 2004-01-02 EP disclosed
WO-2002076975-A1 CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA S.A. (FR) 2002-10-03 WO disclosed